Description
LXH254 is a type II RAF inhibitor.
| Product Unit Size | Cost | Quantity | Stock |
|---|
LXH254 is a type II RAF inhibitor.
| Cas No. | 1800398-38-2 |
|---|---|
| Purity | ≥99% |
| Formula | C25H25F3N4O4 |
| Formula Wt. | 502.49 |
| IUPAC Name | N-[3-[2-(2-hydroxyethoxy)-6-morpholin-4-ylpyridin-4-yl]-4-methylphenyl]-2-(trifluoromethyl)pyridine-4-carboxamide |
| Synonym | Naporafenib |
| Appearance | White powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Monaco K, Delach S, Yuan J, et al. LXH254, a potent and selective ARAF-sparing inhibitor of BRAF and CRAF for the treatment of MAPK-driven tumors. Clin Cancer Res. 2021 Apr 1;27(7):2061-2073. PMID: 33355204
Park S, Kim T, Cho S, et al. Combined blockade of polo-like kinase and pan-RAF is effective against NRAS-mutant non-small cell lung cancer cells. Cancer Lett. 2020 Dec 28;495:135-144. PMID: 32979462
Fluoroquinolone; topoisomerase IV and bacterial...
Antifungal agent with neuroprotective activity....
AR antagonist.
Mouse selective STING agonist.
Synthesis impurity
Endogenous peptide neurotransmitter, involved i...
Catalyzes hydrolysis of asparagine.
Topoisomerase II inhibitor, RPA modulator.
Side chain commonly attached to taxanes.
Endogenous quaternary ammonium, required for fa...
DNA alkylator.
Oxazolidone derivative; Factor Xa inhibitor.
Sesquiterpene lactone derived from Artemesia; m...
Thrombin substrate used to measure thrombin act...
Viral M2 proton channel blocker.
Endogenous antimicrobial peptide, binds bacteri...
Analog of rapamycin.
Hydrazine; L-amino acid decarboxylase inhibitor...
Semi-synthetic diterpene originally found in Ta...
Inhibitor of PTEFb/CDK9.